Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

THRX 15.25 -0.07 (-0.46%)
price chart
Technical Insights on Theravance Inc. (NASDAQ:THRX)
Theravance Inc. (NASDAQ:THRX) was one of the Russell 2000's biggest losers for November 10 as the stock slid 5.82% to $13.44, a loss of $0.83 per share.
Why Theravance Inc.'s 22% Drop Isn't What It Appears
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Theravance, Inc. and Theravance Biopharma, Inc. Announce Completion of ...  Marketwired (press release)
Related articles »  
Theravance: 2 Hidden Catalysts Will Boost Sales
Theravance: 2 Hidden Catalysts Will Boost Sales. Oct. 27, 2014 8:55 AM ET | About: Theravance, Inc. (THRX), Includes: AZN, GSK, TBPH by: Early Retiree Subscribers to SA PRO had an early look at this article.
Related articles »  
Theravance, Inc. Appoints Michael W. Aguiar as President and Chief Executive ...
Mr. Aguiar will replace Rick E Winningham who has resigned as Chief Executive Officer of Theravance effective August 15, 2014. Mr. Winningham will remain Chairman of the Board of Directors of Theravance, Inc. and will transition to full time Chief ...
Theravance's (THRX) CEO Rick Winningham on Q2 2014 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Theravance, Inc. Announces May 15 Record Date and June 2 Share Issue Date ...
SOUTH SAN FRANCISCO, CA, May 06, 2014 (Marketwired via COMTEX) -- Theravance, Inc. THRX, +3.85% (the "Company" or "Theravance") has announced the record date of May 15, 2014 for the Company's strategic separation into two independent, ...
Theravance, Inc. (THRX) Announces Record Date for Separation Into Two ...  StreetInsider.com (subscription)
Theravance's (THRX) CEO Rick Winningham on Q1 2014 Results - Earnings ...  Seeking Alpha
Related articles »  
When Is It Time To Accumulate Theravance?
Theravance (NASDAQ:THRX) has resumed its horrific decline since peaking in July 2014, when the stock was $32.53. It is down at a yearly low, closing recently at $14.27.
Update: Theravance Reveals Interesting Bits Of Information At CS Conference
At today's Credit Suisse conference, Theravance revealed for the first time a rough time table for the closed triple's ongoing phase 3 studies.
Momentum Stocks: Theravance Biopharma, Inc. (NASDAQ:TBPH), 22nd Century ...  Street Newswire (registration)
Today's Watch List: Merck & Co. Inc. (NYSE:MRK), Exelon Corporation ...  Property Mentor
Related articles »  
Theravance Inc (THRX) Drops 5.82% on November 10
Theravance Inc (THRX) was one of the Russell 2000's biggest losers for November 10 as the stock slid 5.82% to $13.44, a loss of $0.83 per share.
Related articles »  
Update: Why Theravance Jumped
More interesting would have been an apples-to-apples comparison between Anoro and Boehringer's investigational tiotropium + olodaterol combination.
In the Face of Sales Erosion of Key Brands by Novel Formulations ...  MarketWatch
Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function ...  SYS-CON Media (press release)
Related articles »  
Theravance, Inc. Appoints Theodore J. Witek, Jr. as Senior Vice President ...
SOUTH SAN FRANCISCO, CA, Jul 02, 2014 (Marketwired via COMTEX) -- Theravance, Inc. THRX, -0.46% ("Theravance"), A Royalty Management Company, today announced the appointment of Theodore J. Witek, Jr.
Related articles »